Clinical Microbiology Market
Segments - by Products (Laboratory Instruments [Incubators, Gram Stainers, Bacterial Colony Counters, Autoclave Sterilizers, Petri Dish Fillers, and Automated Culture Systems], Microbiology Analyzers [Molecular Diagnostic Instruments, Microscopes, and Mass Spectrometers], and Reagents), Applications (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others), and Regions (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2021 – 2028
The global clinical microbiology market size was valued at USD 12.42 billion in 2020 and is projected to expand at a substantial CAGR during the forecast period, 2021 – 2028. The growth of the market is attributed to the constant increasing occurrences of infectious diseases and chronic illness.
Clinical microbiology is a medical discipline that includes a wide range of methodologies, which are primarily focused on finding solutions in terms of isolating, identifying, and monitoring microorganisms. For various treatment process of chronic illness and infectious, researchers and scientists have largely depended on to study microorganisms for treatment purposes and clinical microbiology is a key aspect. It is still heavily hinged on phenotypic methods for accurate identification and classification. Clinical microbiology involves the study of different characteristics of pathogens or mechanisms involving growth and infection and their various modes of transmission. This discipline was able to differentiate four different kinds of microorganisms causing infectious diseases, namely fungi, viruses, bacteria, and parasites. Using the knowledge acquired from clinical microbiology, doctors and physicians are able to devise treatments and cures of numerous diseases, help to identify potential health risks at a large extent, and learn the evolution if required of certain disorders.
The rapid development of the clinical microbiology market can be attributed to the wide R&D activities as well as rising cases of acute and chronic illness across the globe. According to the Centers for Disease Control and Prevention (CDC), there are over 10,000 cases for Tuberculosis, 55,000 cases of salmonella, 600 cases for meningococcal disease, and 36,000 cases for Lyme disease prevailed in the US alone in 2018.
Market Trends, Drivers, Restraints, and Opportunities
- Rising prevalence of acute illness and chronic diseases along with the rising cases of viral infection globally are key drivers for the market growth.
- Rapid expansion of hospitals and healthcare centers to advance medical facilities related to clinical microbiology to learn and analysis of several diseases are key factors boosting the market expansion.
- Favorable regulations from several governments and administrative bodies to promote clinical microbiology diagnostics are expected to propel the market growth.
- The COVID-19 pandemic has accelerated the growth of the global clinical microbiology market. Scientists and researchers of microbiology are working towards finding a vaccine to prevent and curb the spread of the virus. This is expected to spur the market growth.
- Shortage of skilled and trained professionals in handling the microbiological laboratories, which involve intercepting and processing specimens and samples. This is a key challenge that can hinder the growth on the global clinical microbiology market in the coming years.
- Limited training programs and a smaller number of professionals graduated from microbiology as a discipline especially in developing regions. This acts as a major restraining factor that can hamper the market expansion.
Scope of the Report
The report on the global clinical microbiology market size includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Clinical Microbiology Market Size - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2020 |
|
Historic Data |
2018–2019 |
|
Forecast Period |
2021–2028 |
|
Segmentation |
Products (Laboratory Instruments [Incubators, Gram Stainers, Bacterial Colony Counters, Autoclave Sterilizers, Petri Dish Fillers, and Automated Culture Systems], Microbiology Analyzers [Molecular Diagnostic Instruments, Microscopes, and Mass Spectrometers], and Reagents), and Applications (Respiratory Diseases, Bloodstream Infections, Gastrointestinal Diseases, Sexually Transmitted Diseases, Urinary Tract Infections, Periodontal Diseases, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
bioMerieux S.A; Cepheid Inc.; Danaher Corporation; Bruker Corporation; Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc. |
Global Clinical Microbiology Market Size Segment Insights
Reagents segment to account for a large market share
On the basis of products, the global clinical microbiology market size is segmented into laboratory instruments, microbiology analyzers, and reagents. The laboratory instruments segment is further segmented into incubators, gram stainers, bacterial colony counters, autoclave sterilizers, petri dish fillers, and automated culture systems. The microbiology analyzers segment is sub-divided into molecular diagnostic instruments, microscopes, and mass spectrometers. The reagents segment held a large revenue share of 60% of the global market owing to wide adoption of reagent products as primers, kits, solutions, and master mixes that are used for various diagnostic assays. This segment growth is also due to increasing investments and funding in their research and development activities with respect to their therapeutic and analytical projects.
Respiratory diseases segment to dominate the market
Based on applications, the market is divided into respiratory diseases, bloodstream infections, gastrointestinal diseases, sexually transmitted diseases, urinary tract infections, periodontal diseases, and other diseases. The respiratory diseases segment is expected to dominate the market in the coming years. The segment growth is attributed to the rising levels of air pollution along with the increasing industrialization, which resulted in the sudden escalation in the occurrence of respiratory diseases. The respiratory diseases normally carry pathogens, which are contagious in nature that can spread rapidly.
North America to register a high CAGR
In terms of regions, the global clinical microbiology market is classified as North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America represented a large share in the global clinical microbiology market in 2002 and is projected to register a high CAGR during the forecast period. The regional market growth is accredited to the fact that there is high development in the healthcare sector and wide adoption of advanced technology besides the rapid growth of several industries. Meanwhile, the market in Asia Pacific is expecting to grow at a fast rate during the forecast period 2021-2028. Japan is currently one of the top countries that allows massive development for solid technology in microbial testing.
Segments
Segments covered in the reportThe global clinical microbiology market size has been segmented in terms of
Products
- Laboratory Instruments
- Incubators
- Gram Stainers
- Bacterial Colony Counters
- Autoclave Sterilizers
- Petri Dish Fillers
- Automated Culture Systems
- Microbiology Analyzers
- Molecular Diagnostic Instruments
- Microscopes
- Mass Spectrometers
- Reagents
- Respiratory Diseases
- Bloodstream Infections
- Gastrointestinal Diseases
- Sexually Transmitted Diseases
- Urinary Tract Infections
- Periodontal Diseases
- Others
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
- bioMerieux S.A
- Cepheid Inc.
- Danaher Corporation
- Bruker Corporation
- Becton Dickinson & Company
- Hologic Inc.
- Roche Diagnostics
- Alere Inc.
Competitive Landscape
Some of the major players in the global clinical microbiology market are bioMerieux S.A; Cepheid Inc.; Danaher Corporation; Bruker Corporation; Becton Dickinson & Company; Hologic Inc.; Roche Diagnostics; and Alere Inc. Most of these players are currently engaged in strategic initiatives including mergers & acquisitions, promoting awareness, and new product development that can help them to formulate innovative designs and automated systems for the study for clinical microbiology.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Microbiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Microbiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Microbiology Market - Supply Chain
4.5. Global Clinical Microbiology Market Forecast
4.5.1. Clinical Microbiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Microbiology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Clinical Microbiology Market Absolute $ Opportunity
5. Global Clinical Microbiology Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Clinical Microbiology Market Size and Volume Forecast by Types
5.3.1. Laboratory Instruments
5.3.2. Microbiology Analyzers
5.3.3. Reagents
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Clinical Microbiology Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Clinical Microbiology Market Size and Volume Forecast by Applications
6.3.1. Respiratory Diseases
6.3.2. Bloodstream Infections
6.3.3. Gastrointestinal Diseases
6.3.4. Sexually Transmitted Diseases
6.3.5. Urinary Tract Infections
6.3.6. Periodontal Diseases
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Clinical Microbiology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Clinical Microbiology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Clinical Microbiology Demand Share Forecast, 2019-2026
8. North America Clinical Microbiology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Clinical Microbiology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Clinical Microbiology Market Size and Volume Forecast by Types
8.4.1. Laboratory Instruments
8.4.2. Microbiology Analyzers
8.4.3. Reagents
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Clinical Microbiology Market Size and Volume Forecast by Applications
8.7.1. Respiratory Diseases
8.7.2. Bloodstream Infections
8.7.3. Gastrointestinal Diseases
8.7.4. Sexually Transmitted Diseases
8.7.5. Urinary Tract Infections
8.7.6. Periodontal Diseases
8.7.7. Others
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Clinical Microbiology Demand Share Forecast, 2019-2026
9. Latin America Clinical Microbiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Clinical Microbiology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Clinical Microbiology Market Size and Volume Forecast by Types
9.4.1. Laboratory Instruments
9.4.2. Microbiology Analyzers
9.4.3. Reagents
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Clinical Microbiology Market Size and Volume Forecast by Applications
9.7.1. Respiratory Diseases
9.7.2. Bloodstream Infections
9.7.3. Gastrointestinal Diseases
9.7.4. Sexually Transmitted Diseases
9.7.5. Urinary Tract Infections
9.7.6. Periodontal Diseases
9.7.7. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Clinical Microbiology Demand Share Forecast, 2019-2026
10. Europe Clinical Microbiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Clinical Microbiology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Clinical Microbiology Market Size and Volume Forecast by Types
10.4.1. Laboratory Instruments
10.4.2. Microbiology Analyzers
10.4.3. Reagents
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Clinical Microbiology Market Size and Volume Forecast by Applications
10.7.1. Respiratory Diseases
10.7.2. Bloodstream Infections
10.7.3. Gastrointestinal Diseases
10.7.4. Sexually Transmitted Diseases
10.7.5. Urinary Tract Infections
10.7.6. Periodontal Diseases
10.7.7. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Clinical Microbiology Demand Share Forecast, 2019-2026
11. Asia Pacific Clinical Microbiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Types
11.4.1. Laboratory Instruments
11.4.2. Microbiology Analyzers
11.4.3. Reagents
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Applications
11.7.1. Respiratory Diseases
11.7.2. Bloodstream Infections
11.7.3. Gastrointestinal Diseases
11.7.4. Sexually Transmitted Diseases
11.7.5. Urinary Tract Infections
11.7.6. Periodontal Diseases
11.7.7. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Clinical Microbiology Demand Share Forecast, 2019-2026
12. Middle East & Africa Clinical Microbiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Types
12.4.1. Laboratory Instruments
12.4.2. Microbiology Analyzers
12.4.3. Reagents
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Applications
12.7.1. Respiratory Diseases
12.7.2. Bloodstream Infections
12.7.3. Gastrointestinal Diseases
12.7.4. Sexually Transmitted Diseases
12.7.5. Urinary Tract Infections
12.7.6. Periodontal Diseases
12.7.7. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Clinical Microbiology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Clinical Microbiology Market: Market Share Analysis
13.2. Clinical Microbiology Distributors and Customers
13.3. Clinical Microbiology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. bioMerieux S.A
13.4.2. Cepheid Inc.
13.4.3. Danaher Corporation
13.4.4. Bruker Corporation
13.4.5. Becton Dickinson & Company
13.4.6. Hologic Inc.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Clinical Microbiology Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Clinical Microbiology Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Clinical Microbiology Market - Supply Chain
4.5. Global Clinical Microbiology Market Forecast
4.5.1. Clinical Microbiology Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Clinical Microbiology Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Clinical Microbiology Market Absolute $ Opportunity
5. Global Clinical Microbiology Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Clinical Microbiology Market Size and Volume Forecast by Types
5.3.1. Laboratory Instruments
5.3.2. Microbiology Analyzers
5.3.3. Reagents
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Clinical Microbiology Market Analysis and Forecast by Applications
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Applications
6.2.2. Y-o-Y Growth Projections by Applications
6.3. Clinical Microbiology Market Size and Volume Forecast by Applications
6.3.1. Respiratory Diseases
6.3.2. Bloodstream Infections
6.3.3. Gastrointestinal Diseases
6.3.4. Sexually Transmitted Diseases
6.3.5. Urinary Tract Infections
6.3.6. Periodontal Diseases
6.3.7. Others
6.4. Absolute $ Opportunity Assessment by Applications
6.5. Market Attractiveness/Growth Potential Analysis by Applications
7. Global Clinical Microbiology Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Clinical Microbiology Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Clinical Microbiology Demand Share Forecast, 2019-2026
8. North America Clinical Microbiology Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Clinical Microbiology Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Clinical Microbiology Market Size and Volume Forecast by Types
8.4.1. Laboratory Instruments
8.4.2. Microbiology Analyzers
8.4.3. Reagents
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Clinical Microbiology Market Size and Volume Forecast by Applications
8.7.1. Respiratory Diseases
8.7.2. Bloodstream Infections
8.7.3. Gastrointestinal Diseases
8.7.4. Sexually Transmitted Diseases
8.7.5. Urinary Tract Infections
8.7.6. Periodontal Diseases
8.7.7. Others
8.8. Basis Point Share (BPS) Analysis by Applications
8.9. Y-o-Y Growth Projections by Applications
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Clinical Microbiology Demand Share Forecast, 2019-2026
9. Latin America Clinical Microbiology Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Clinical Microbiology Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Clinical Microbiology Market Size and Volume Forecast by Types
9.4.1. Laboratory Instruments
9.4.2. Microbiology Analyzers
9.4.3. Reagents
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Clinical Microbiology Market Size and Volume Forecast by Applications
9.7.1. Respiratory Diseases
9.7.2. Bloodstream Infections
9.7.3. Gastrointestinal Diseases
9.7.4. Sexually Transmitted Diseases
9.7.5. Urinary Tract Infections
9.7.6. Periodontal Diseases
9.7.7. Others
9.8. Basis Point Share (BPS) Analysis by Applications
9.9. Y-o-Y Growth Projections by Applications
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Clinical Microbiology Demand Share Forecast, 2019-2026
10. Europe Clinical Microbiology Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Clinical Microbiology Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Clinical Microbiology Market Size and Volume Forecast by Types
10.4.1. Laboratory Instruments
10.4.2. Microbiology Analyzers
10.4.3. Reagents
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Clinical Microbiology Market Size and Volume Forecast by Applications
10.7.1. Respiratory Diseases
10.7.2. Bloodstream Infections
10.7.3. Gastrointestinal Diseases
10.7.4. Sexually Transmitted Diseases
10.7.5. Urinary Tract Infections
10.7.6. Periodontal Diseases
10.7.7. Others
10.8. Basis Point Share (BPS) Analysis by Applications
10.9. Y-o-Y Growth Projections by Applications
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Clinical Microbiology Demand Share Forecast, 2019-2026
11. Asia Pacific Clinical Microbiology Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Types
11.4.1. Laboratory Instruments
11.4.2. Microbiology Analyzers
11.4.3. Reagents
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Clinical Microbiology Market Size and Volume Forecast by Applications
11.7.1. Respiratory Diseases
11.7.2. Bloodstream Infections
11.7.3. Gastrointestinal Diseases
11.7.4. Sexually Transmitted Diseases
11.7.5. Urinary Tract Infections
11.7.6. Periodontal Diseases
11.7.7. Others
11.8. Basis Point Share (BPS) Analysis by Applications
11.9. Y-o-Y Growth Projections by Applications
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Clinical Microbiology Demand Share Forecast, 2019-2026
12. Middle East & Africa Clinical Microbiology Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Types
12.4.1. Laboratory Instruments
12.4.2. Microbiology Analyzers
12.4.3. Reagents
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Clinical Microbiology Market Size and Volume Forecast by Applications
12.7.1. Respiratory Diseases
12.7.2. Bloodstream Infections
12.7.3. Gastrointestinal Diseases
12.7.4. Sexually Transmitted Diseases
12.7.5. Urinary Tract Infections
12.7.6. Periodontal Diseases
12.7.7. Others
12.8. Basis Point Share (BPS) Analysis by Applications
12.9. Y-o-Y Growth Projections by Applications
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Clinical Microbiology Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Clinical Microbiology Market: Market Share Analysis
13.2. Clinical Microbiology Distributors and Customers
13.3. Clinical Microbiology Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. bioMerieux S.A
13.4.2. Cepheid Inc.
13.4.3. Danaher Corporation
13.4.4. Bruker Corporation
13.4.5. Becton Dickinson & Company
13.4.6. Hologic Inc.
Our Clients
Related Reports
Some other reports from this category!
